Literature DB >> 11522881

Conversion between bromcresol green- and bromcresol purple-measured albumin in renal disease.

C M Clase1, M W St Pierre, D N Churchill.   

Abstract

BACKGROUND: Albumin measured by a bromcresol purple dye-binding assay (Alb(BCP)) agrees more closely with the gold standard of immunonephelometry than does bromcresol green (Alb(BCG)) measurement. Both tests are in current clinical use. A method for converting between the two would be useful.
METHODS: We measured albumin by bromcresol green and bromcresol purple in 535 patients, 155 of whom had renal disease. We randomly divided data from the patients with renal disease into two equal-sized sets, and used one set to derive, and the remaining set to validate, a regression equation relating the two values.
RESULTS: The relationship Alb(BCG)=5.5+Alb(BCP) performed very well in both the renal patient validation set and in the data from 380 unselected in-patients and out-patients. Intraclass correlations for agreement between measured Alb(BCG) and predicted Alb(BCG) was 0.98 in both analyses.
CONCLUSIONS: The ability to convert between these measurements will be of use in clinical situations where the absolute value of the serum albumin is important, when data from laboratories using different methodologies must be combined, and in the application of the Modification of Diet in Renal Disease formula to estimate glomerular filtration rate in patients whose albumin has been measured by bromcresol purple.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11522881     DOI: 10.1093/ndt/16.9.1925

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  18 in total

1.  Role of residual renal function in phosphate control and anemia management in chronic hemodialysis patients.

Authors:  E Lars Penne; Neelke C van der Weerd; Muriel P C Grooteman; Albert H A Mazairac; Marinus A van den Dorpel; Menso J Nubé; Michiel L Bots; Renée Lévesque; Piet M ter Wee; Peter J Blankestijn
Journal:  Clin J Am Soc Nephrol       Date:  2010-10-28       Impact factor: 8.237

2.  Clinical predictors of decline in nutritional parameters over time in ESRD.

Authors:  Claire H den Hoedt; Michiel L Bots; Muriel P C Grooteman; Neelke C van der Weerd; E Lars Penne; Albert H A Mazairac; Renée Levesque; Peter J Blankestijn; Menso J Nubé; Piet M ter Wee; Marinus A van den Dorpel
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-23       Impact factor: 8.237

3.  Associations among Serum Beta 2 Microglobulin, Malnutrition, Inflammation, and Advanced Cardiovascular Event in Patients with Chronic Kidney Disease.

Authors:  Hung-Chieh Wu; Lin-Chien Lee; Wei-Jie Wang
Journal:  J Clin Lab Anal       Date:  2016-09-20       Impact factor: 2.352

4.  Prehemodialysis care by dietitians and first-year mortality after initiation of hemodialysis.

Authors:  Yelena Slinin; Haifeng Guo; David T Gilbertson; Lih-Wen Mau; Kristine Ensrud; Allan J Collins; Areef Ishani
Journal:  Am J Kidney Dis       Date:  2011-06-29       Impact factor: 8.860

5.  Heart failure severity scoring system and medical- and health-related quality-of-life outcomes: the HEMO study.

Authors:  Kelly V Liang; Francis Pike; Christos Argyropoulos; Lisa Weissfeld; Jeffrey Teuteberg; Mary Amanda Dew; Mark L Unruh
Journal:  Am J Kidney Dis       Date:  2011-05-06       Impact factor: 8.860

Review 6.  IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome.

Authors:  Agnes Trautmann; Olivia Boyer; Elisabeth Hodson; Arvind Bagga; Debbie S Gipson; Susan Samuel; Jack Wetzels; Khalid Alhasan; Sushmita Banerjee; Rajendra Bhimma; Melvin Bonilla-Felix; Francisco Cano; Martin Christian; Deirdre Hahn; Hee Gyung Kang; Koichi Nakanishi; Hesham Safouh; Howard Trachtman; Hong Xu; Wendy Cook; Marina Vivarelli; Dieter Haffner
Journal:  Pediatr Nephrol       Date:  2022-10-21       Impact factor: 3.651

7.  Decreased total antioxidant capacity in plasma, but not tissue, in experimental colitis.

Authors:  José Wander Breganó; Jane Bandeira Dichi; Décio Sabbatini Barbosa; Mirian Zebian El Kadri; Tiemi Matsuo; Maria Aparecida Rodrigues; Rubens Cecchini; Isaias Dichi
Journal:  Dig Dis Sci       Date:  2008-08-22       Impact factor: 3.199

8.  Should we still focus that much on cardiovascular mortality in end stage renal disease patients? The CONvective TRAnsport STudy.

Authors:  Claire H den Hoedt; Michiel L Bots; Muriel P C Grooteman; Albert H A Mazairac; E Lars Penne; Neelke C van der Weerd; Piet M Ter Wee; Menso J Nubé; Renée Levesque; Peter J Blankestijn; Marinus A van den Dorpel
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

9.  Analysis of time to event outcomes in randomized controlled trials by generalized additive models.

Authors:  Christos Argyropoulos; Mark L Unruh
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

10.  Interdialytic weight gain, systolic blood pressure, serum albumin, and C-reactive protein levels change in chronic dialysis patients prior to death.

Authors:  Len A Usvyat; Claudia Barth; Inga Bayh; Michael Etter; Gero D von Gersdorff; Aileen Grassmann; Adrian M Guinsburg; Maggie Lam; Daniele Marcelli; Cristina Marelli; Laura Scatizzi; Mathias Schaller; Adam Tashman; Ted Toffelmire; Stephan Thijssen; Jeroen P Kooman; Frank M van der Sande; Nathan W Levin; Yuedong Wang; Peter Kotanko
Journal:  Kidney Int       Date:  2013-03-20       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.